@diaryofakidneyw.bsky.social@castltrastondrs.medsky.network 🚨What happens when your kidney function looks good,but something is still wrong?
Brittany shares her 8-year journey to an #IgANephropathy(IgAN) diagnosis, including proteinuria, kidney biopsy,treatment & the importance of self-advocacy
kidneycareuk.org/get-support/...
@diaryofakidneyw.bsky.social@nephtimes.bsky.social 🚨What happens when your kidney function looks good, but something is still wrong?
Brittany shares her 8-year journey to an #IgANephropathy(IgAN) diagnosis, including proteinuria, kidney biopsy, treatment and the importance of self-advocacy.
@diaryofakidneyw.bsky.social@jonathanpollack.bsky.social 🚨What happens when your kidney function looks good, but something is still wrong?
Brittany shares her 8-year journey to an #IgANephropathy(IgAN) diagnosis, including proteinuria, kidney biopsy, treatment & the importance of self-advocacy
@diaryofakidneyw.bsky.social@kireports.bsky.social 🚨What happens when your kidney function looks good, but something is still wrong?
Brittany shares her 8-year journey to an #IgANephropathy(IgAN) diagnosis, including proteinuria, kidney biopsy, treatment and the importance of self-advocacy.
@diaryofakidneyw.bsky.social@kidneyint.bsky.social 🚨What happens when your kidney function looks good, but something is still wrong?
Brittany shares her 8-year journey to an #IgANephropathy(IgAN) diagnosis, including proteinuria, kidney biopsy, treatment and the importance of self-advocacy.
@diaryofakidneyw.bsky.social🚨What happens when your kidney function looks good, but something is still wrong?
Brittany shares her 8-year journey to an IgA nephropathy (IgAN) diagnosis, including proteinuria, kidney biopsy, treatment and the importance of self-advocacy.
@jonathanpollack.bsky.socialIf somebody could hurry up on this, that'd be swell.
@kidneyint.bsky.socialMeeting Report
Outcomes from the International Society of Nephrology forum on complement therapeutics in C3 glomerulopathy and IgA nephropathy
doi.org/10.1016/j.kint.2026.08.007
#NephSky #MedSky #OpenAccess #C3G #C3Glomerulopathy #IgAN #IgANephropathy #ComplementSystem #GlomerularDisease
@pharmaphorum.bsky.social#Roche has staked a claim to the increasingly crowded #IgAnephropathy (IgAN) category, which has seen half a dozen new therapies approved by the FDA in the last decade, with plenty more in late-stage development.
